Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check22 days agoChange DetectedAn NIH-wide notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.SummaryDifference0.3%

- Check29 days agoChange DetectedThe footer now displays ClinicalTrials.gov revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check36 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, indicating an incremental site update.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label updated to v3.7.0, replacing the old v3.6.6 in the page footer. This reflects a new site release without modifying study data or content.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page history now shows a new revision label v3.6.6, replacing the previous v3.6.5, indicating a minor update to the page's revision metadata.SummaryDifference0.0%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.